Non-A, non-B hepatitis virus and heat-treated blood products
Komuro, K.; Okuyama, K.; Fukushima, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 46(12): 2744-2749
1988
ISSN/ISBN: 0047-1852 PMID: 3149348 Document Number: 310203
Document emailed within 1 workday
Related Documents
Hitzler, W.E.; Runkel, S. 2001: Screening of Blood Donations by Hepatitis C Virus Polymerase Chain Reaction (HCV-PCR) Improves Safety of Blood Products by Window Period Reduction Clinical Laboratory 47(5-6): 219-222Rouzioux, C.; Chamaret, S.; Montagnier, L.; Carnelli, V.; Rolland, G.; Mannucci, P.M. 1985: Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIIi concentrate Lancet 1(8423): 271-272
Kania, D.; Sangaré, L.; Sakandé, J.; Koanda, A.; Nébié, Y.K.; Zerbo, O.; Combasséré, A.W.; Guissou, I.P.; Rouet, F.ço. 2009: A new strategy to improve the cost-effectiveness of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis testing of blood donations in sub-Saharan Africa: a pilot study in Burkina Faso Transfusion 49(10): 2237-2240
Pivert, A.; Payan, C.; Lunel, F.; C, E.R.T. A. 2004: Comparaison des cinétiques de l'ARN et de l'antigène de capside du virus de l'hépatite C dans le suivi thérapeutique des patients co-infectés par le virus de l'hépatite C et le virus de l'immunodéficience humaine, traités par bithérapie interféron-ribavirine, dans le cadre du protocole RIBAVIC - Comparison of hepatitis C viral RNA and core antigen kinetics in the therapeutic follow up of hepatitis C virus and human immunodeficiency virus co-infected patients, treated by bitherapy interferon-ribavirin, within the framework of RIBAVIC protocol Pathologie et Biologie 52(9): 522-528
Ruebsaamen, M. 1995: Liability for HIV infection by blood and blood products: A summary of the most important results of the final report of the 3rd fact-finding committee HIV infections by blood and blood products of the 12th German Bundestag AIDS-Forschung 10(6): 305-318
Viet, L.; Lan, N.T.N.; Ty, P.X.; Björkvoll, B.ör.; Hoel, H.; Gutteberg, T.; Husebekk, A.; Larsen, S.; Skjerve, E.; Husum, H. 2012: Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Vietnam Indian Journal of Medical Research 136(1): 74-81
Myl'nikov, A.I.; Lytsar', B.N.; Gorbatok, L.E.; Skvortsov, S.V.; Poliakova, I.I.; Gorbatiuk, V.I. 1994: The detectability of the hepatitis B surface antigen and antibodies to the hepatitis C virus in serviceman blood donors Voenno-Meditsinskii Zhurnal 3: 44-45; 79
Echevarría Mayo, Jé.M.; León Rega, P. 2003: Sreening of blood for antibody to hepatitis B virus core antigen and prevention of post-transfusional hepatitis C before 1990 Medicina Clinica 120(10): 397
Adhikari, D.; De, M.; Paladhi, P.K.; Chandra, S.; Bhattacharya, D.K. 1991: Prevalence of hepatitis B virus (HBV) markers and human immunodeficiency virus (HIV) in employees of a blood transfusion centre Journal of the Indian Medical Association 89(7): 190-192
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Rong, G.; Sun, J.; Zhou, J. 1998: Cloning, sequencing and expression of hepatitis e virus structural gene in E. coli and application of the recombinant products for diagnosis Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 12(2): 169-172
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Sutcliffe, S.; Taha, T.E.; Kumwenda, N.I.; Taylor, E.; Liomba, G.N. 2002: HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi Journal of Acquired Immune Deficiency Syndromes 31(1): 90-97
Chung, D.C.; Ko, Y.C.; Chen, C.J.; Chen, E.R.; Wu, C.C.; Wu, P.S. 1989: Seroepidemiology of hepatitis B virus, hepatitis D virus, and human immunodeficiency virus infections among parenteral drug abusers in southern Taiwan Journal of Medical Virology 28(4): 215-218
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Péter, S.; Schnitzer, F. 1994: The problem of obtaining virus-free blood products Orvosi Hetilap 135(11): 601
Ruzibakiev, R.; Kato, H.; Ueda, R.; Yuldasheva, N.; Hegay, T.; Avazova, D.; Kurbanov, F.; Zalalieva, M.; Tuichiev, L.; Achundjanov, B.; Mizokami, M. 2001: Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan Intervirology 44(6): 327-332
Brown, F.; Meyer, R.F.; Law, M.; Kramer, E.; Newman, J.F. 1999: A universal virus inactivant for decontaminating blood and biopharmaceutical products Developments in Biological Standardization 99: 119-130